Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

When Rheumatology and Cancer Collide

Simon M. Helfgott, MD  |  Issue: March 2015  |  March 1, 2015

A short while later, a call from the radiologist confirmed my fears. Maria’s chest X-ray had demonstrated a large, irregular mass in her right upper lobe that was partially collapsing the lung. Maria had lung cancer.

Les Doigts Hippocratiques

Some medical historians consider clubbing to be the oldest sign in medicine. Nearly 2,500 years ago, Hippocrates astutely recognized that digital clubbing was a sinister sign of illness in the chest, vividly describing that, “if you put your ear against the chest you can hear it [pus] seethe inside like sour wine.”1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Although the link between clubbing and lung disease remains undisputed, the underpinnings of this relationship have remained obscure. The first clue came from the work of the prolific French neurologist, Pierre Marie, MD, and the Austrian internist, Eugen von Bamberger, MD, who, working separately, described the degree of bone proliferation and periosteal involvement seen in clubbing, leading Dr. Marie to rename the condition, pulmonary hypertrophic osteoarthropathy.

A second clue arrived 40 years later with the publication of a small series of British patients with clubbing. Several of them were initially thought to have RA, but were found instead to have a pulmonary malignancy without evidence for empyema, tuberculosis or lung abscesses, which had been the most commonly observed findings in patients with clubbing.2

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

For a while, humoral factors and excessive vagal nerve stimulation (vagotomy helped lessen the hand pain in a few patients) were considered to be the prime mediators of clubbing, but neither of these vague explanations was intellectually satisfying. About 30 years ago, it was proposed that an accumulation of megakaryocyte fragments or platelet aggregates that bypassed the lung capillary network in various cardiac and pulmonary diseases could increase finger vascularity and permeability and promote mesenchymal cell growth to produce periosteal new bone formation and clubbing via the release of platelet-derived growth factor (PDGF) from the small vessels of the fingertips.3 Subsequent research identified vascular endothelial growth factor (VEGF) as the likely critical cytokine in the pathogenesis of the periostitis in clubbing.4

Another pivotal observation was the identification of a specific genetic mutation of a prostaglandin transporter enzyme in many patients afflicted with the familial form of hypertrophic osteoarthropathy, which markedly elevated their levels of circulating prostaglandin E2 (PGE2). PGE2 is a potent stimulator of VEGF-mediated osteoblast activation and bone formation and its striking concentration in certain individuals with clubbing may obviate their need to have a chest full of “seething pus.”

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:autoimmunityCancerDiagnosisHelfgottinflammationRheumatoid arthritis

Related Articles
    Lost and found

    The History of ACE Inhibitors in Scleroderma Renal Crisis

    February 16, 2021

    Scleroderma renal crisis is a true medical emergency in rheumatology, one that requires prompt diagnosis and treatment. Here, we review the historic introduction of the angiotensin-converting enzyme inhibitors in this context, and highlight management and key questions moving forward. Background Awareness of renal disease in scleroderma dates back many years. The revered physician William Osler…

    2014 ACR/ARHP Annual Meeting: Autoimmune Connective Tissue Diseases and Cancer

    April 1, 2015

    Links between autoimmunity, malignancy prompt rheumatologists to include cancer screening for patients

    Case Report: A Patient’s Clubbing & Arthralgias Resist Diagnosis

    April 15, 2020

    A 59-year-old woman presented to our rheumatology clinic with a six-month history of a symmetric polyarthritis. She initially experienced pain in both knees. As time progressed, she began to notice pain in her ankles, hips, shoulders, hands and feet. She experienced joint stiffness lasting for more than 30 minutes every morning. She also described worsening…

    Malignant Complications: Screening for Cancer in Rheumatic Diseases

    July 13, 2020

    Cancer and autoimmunity have a complex relationship. In a presentation, Ami Shah, MD, MHS, discussed how to use autoantibodies as tools for cancer risk stratification, how to approach cancer screening in individuals with new-onset disease and more…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences